Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Hydroxychloroquine Sulfate Tablets Market is expected to grow at a CAGR of 4.7% from 2020 to 2027

Hydroxychloroquine sulfate tablets are enlisted on the World Health Organization (WHO) list of essential medicines. As an antimalarial drug its mechanism of action comprises increasing the lysosomal pH of the antigen-presenting cells. In the treatment of autoimmune diseases such as rheumatoid arthritis and lupus erythematosus it has been reported to block the toll-like receptor signals to reduce the inflammation. Currently it is under investigation for its therapeutic efficacy for the treatment of COVID-19 infection.

Hydroxychloroquine sulfate tablets are still considered as a first-line drug therapy for geographical regions where chloroquine resistance is not reported. The posology associated with malaria treatment is 400mg weekly starting 2 weeks before exposure and is continued for 4 weeks after leaving the endemic area. It is successfully employed as a DMARD medicine for the treatment of rheumatoid arthritis with the dosage of 400-600 mg/day in the BID, used in combination with corticosteroids or salicylates for better results. The drug also finds application in the treatment of lupus erythematosus in which the drug posology is 200mg single dose per day.

Browse the full report Hydrochloroquine Sulfate Tablets Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/hydroxychloroquine-sulfate-tablets-market

Hospital pharmacies are spearheading the end-user segment for hydroxychloroquine sulfate tablets market. It favors the capability of dispensing a different dose of hydroxychloroquine for different age group patients to prevent overdose toxicity which is fatal. Retail pharmacy is quite popular in the developing regions owing to the presence of a huge generic market for hydroxychloroquine sulfate tablets which are sold at cheap price and it caters to the medical needs of patients residing in remote locations.

Middle East and Africa are currently leading the geography segment for hydroxychloroquine sulfate tablets market. The rising prevalence of malarial infection in the sub-Saharan region responsible for 93% of all known mortality associated with malaria causes tremendous demand for hydroxychloroquine which is still used as a first-line drug therapy. The region receives free medical aid from regulatory bodies such as WHO, Red Cross, etc. for the treatment of malarial infection. Latin America represents the second-largest regional market on account of the presence of a large rain forest area which is a teeming growing for malarial infection. Asia Pacific is keen to register impressive market growth during the forecast period on account of the presence of tropical and subtropical climate in SE Asian countries which favors the spread of malaria-infected mosquitos, furthermore, the cheap generic market further propels the hydroxychloroquine sulfate tablets market growth. In developed regions such as North America and Europe it is used for the treatment of autoimmune disease.

Pharmaceutical companies actively engaged in the manufacturing of hydroxychloroquine sulfate tablets are Mylan Labs Ltd., Teva Pharmaceutical Industries Ltd., Sanofi SA., Sandoz, IPCA Laboratories Ltd., Amneal Pharmaceuticals, Inc., Cadila Healthcare, Bristol Laboratories Ltd., AvKARE, Inc. and Covis Pharmaceutcials, Inc.

Market Key Takeaways:

  • Rising prevalence of malaria in the tropical and subtropical regions of the world
  • Therapeutic efficacy of the hydroxychloroquine sulfate in autoimmune diseases such as rheumatoid arthritis and lupus erythematosus further propels its market growth
  • Affordable reimbursement scenario for the hydroxychloroquine sulfate tablets used as a medication

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Umbilical Cord Clamps Market Is Expected To Grow At A CAGR Of 5.2% From 2020 To 2027

Umbilical cord is a gynecological instrument which is used for clamping the umbilical cord after the live birth in order to separate the newborn from the mother’s placenta. Earlier the waiting period before clamping was considered as 1 minute but current guidelines pertaining to obstetrics and gynecology consider 3 to 5 minutes necessary to ensure optimum blood iron level in the newborn.

Stainless steel umbilical cord clamps are frequently used as they are safe to reuse after they have been rendered sterile by autoclaving with other gynecological devices. They are considered as a green alternative to plastic and polymer-based clamps and hence does not require a cutting tool. Polymer-based umbilical cord clamps will be the largest and fastest-growing product segment during the forecast period. Inherent features such as non-toxic, sterile, and pyrogen-free polymers used in manufacturing clamps which are intended for single-purpose thereby drastically reducing the risk of cross-contamination. It ensures protection against accidental reopening, provides excellent angle movement for the clamps which is gaining huge popularity among gynecologists as it is relatively safe to use due to the presence of grooves and notches on the clippings surface which prevents slipping of the umbilical cord and reduces injury.

Browse the full report Umbilical Cord Clamps Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/umbilical-cord-clamps-market

Hospitals are currently spearheading the end-user segment for the umbilical cord clamps market. It is the first point of contact for middle and low-income households seeking midwifery medical services. Clinics are gaining tremendous market growth owing to its ability to provide obstetrics and gynecological services to people inhabiting in remote locations.

North America is currently dominating the geography segment for the umbilical cord clamps market. The primary factor which determines its market dominance is the significant rise in the number of live births. According to the latest statistics brought forward by the American College of Obstetricians and Gynecology (ACOG) approximately 3.79 million live birth took place in the United States in 2018. Domicile of key manufacturers such as Medline Industries, Inc., Angiplast, Ardo, Medgyn Products Inc., further propel the market growth in the region. Europe is in the 2ndposition in the geography segment for the umbilical cord clamps market. A significant rise in the delayed cord clamping after live births to ensure optimum blood iron level in the newborn primarily determines the market growth in the region. It is expected that the Asia Pacific is keen to register comfortable market growth in the near future on account of huge funding issued by government healthcare agencies for securing women and child health and welfare.

Medical device manufacturers actively manufacturing umbilical cord clamps are Angiplast, Ardo, Medline Industries, Inc., Medgyn Products, Inc., Mediscope International Limited, Surtex Instruments Limited, Denticon Surgical Instruments, Besmed Health Business Corp., Birth Supplies Canada, and R.I.MOS. Srl.

Market Key Takeaways:

  • Increasing number of live births worldwide and rising trend of nurturing new family among adults
  • Significant rise in the demand for polymer-based umbilical cord clamps which are disposable and reduces risk of cross-contamination
  • Effective implementation of guidelines pertaining to obstetrics and gynecology worldwide increasing demand for umbilical cord clamps market

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Household Handheld Intraoral Endoscopes Market Is Expected to Grow at a CAGR of 9.4% from 2020 to 2027

According to the latest research citings provided by the World Health Organization (WHO), approximately 3.5 billion people worldwide are suffering from oral diseases. Intraoral endoscopes were developed in the early 1990s in order to replace the mirrors used by dental and maxillofacial surgeons to achieve an excellent view of the oral cavity and its complications and save the images in the patient’s health record for future reference.

Universal serial bus (USB) is spearheading the product type segment for household handheld intraoral endoscopes market. The primary purpose of USB is to provide connection sot electronic gadgets without the need for docking stations and unnecessary use of cables which adds to the exorbitant maintenance cost in the long run. It provides multitasking features from time to time such as ensuring optimum power supply, integration with imaging software to gain a high-resolution image of the oral cavity, etc. Wi-Fi is anticipated to register nimble market growth during the forecast period on account of the technological advancement in Wi-Fi which provides seamless integration with different versions of imaging software. Furthermore, ergonomic features offered by Wi-Fi such as less interference, a faster and excellent range of connectivity with android, and other ios applications will propel its market growth.

Browse the full report Household Handheld Intraoral Endoscopes Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/household-handheld-intraoral-endoscope-market

The supermarket is presently leading the distribution channel segment for household handheld intraoral endoscopes market. The majority of the consumers opt for a one-stop shopping experience on weekends and hence the supermarket serves as a lucrative platform to exhibit intraoral endoscopes of vast diversity at affordable prices. E-commerce is expected to record comfortable market growth in the near future on account of technological advancement in smartphones and increasing internet penetration to bolster its market growth. E-commerce offers discount coupons on festive seasons which attracts huge consumer base across the globe.

North America is currently dominating the geography segment for household handheld intraoral endoscopes market. A significant increase in gingivitis primarily drives market growth in the region. As per the latest statistics provided by the Center for Disease Control and Prevention (CDC), in the U.S. approximately 16.9% and 31.6% dental caries are untreated in the children and adult population respectively. Furthermore, the domicile of major players such as Carestream Health, SOTA Imaging, Lensiora, ProDent, etc. further bolsters the market growth in the region. Europe is considered as the second-largest regional segment owing to the strategic collaboration between research academia and medical device manufacturers engaged in the technological development of the household handheld intraoral endoscopes in the region. The Asia Pacific is anticipated to be the fastest-growing regional segment during the forecast period on account of increasing dental complications in people habituated to chewing of betel nuts and tobacco products. The competitive market created by the western giants to the local players will further drive the market growth in the region.

Medical device manufacturers actively engaged in the production of household handheld intraoral endoscopes are Apexel, ProDent, Lensiora, DARYOU Dental, KaVo Dental, SOTA Imaging, Carestream Health, DÜRR DENTAL SE, Dongguan Magenta Technology Co., Ltd., and Shenzhen MingNanHuitai Tech.

Market Key Takeaways:

  • Rising prevalence of oral diseases and dental cavities worldwide
  • Technological advancement in the household handheld intraoral endoscopes will accentuate the market growth
  • The supportive regulatory environment provided by the global healthcare agencies to the distribution of household handheld intraoral endoscopes market

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Outlook Market Report Market Reports

Global Bio pharma Buffer Market Is Expected To Grow At A CAGR of 7.2% From 2020 to 2027

Biopharma buffers are used to resist change in the pH and ionic concentration of biochemical process under clinical investigation, buffers basically comprise of acid and base conjugates. Henderson-Hasselbalch equation is critical in determining the pH of the buffer solutions such as acetates, phosphates, carbonates, organic buffers, etc.

Phosphate buffers are presently dominating the type segment for the biopharma buffer market on account of increasing demand from the life science industry and academic research institutes. The major factors responsible for its huge popularity among researchers is its pH, osmolarity, and ionic concentration similar to the human bodily fluids. It is used as the diluent, rinse containers containing cells, reference spectrum to measure protein adsorption on ellipsometry. Acetate buffers are widely employed in molecular biology especially in the purification and precipitation of nucleic acids. Organic buffers will be showcasing magnificent market growth on account of increasing demand for novel drug development such as vaccines, immunotherapy, biologics, etc.

Browse the full report Bio Pharma Buffer Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/bio-pharma-buffer-market

The biopharmaceutical industry is currently leading the end-user segment for the biopharma buffer market. Significant rise in the spread of virulent diseases such as ebola, COVID-19, swine flu, etc. creates the burgeoning requirement for the development of vaccines and novel drugs to prevent the spread and reduce the mortality rate associate with the viral infections. Academia and research institutes worldwide are keen to register rampant market growth owing to the strategic collaboration between pharmaceutical companies to promote breakthrough research and technology to serve mankind. Huge monetary funds provided by governmental healthcare agencies to establish academic research institutes.

North America is currently representing the largest market share in the geography segment for the biopharma buffer market. The key attributes associated with its market dominance are proactive role adopted by healthcare agencies to promote research and development activities for the treatment of infectious and lifestyle disorders in the region. The existence of well-developed healthcare infrastructure and constantly growing biopharmaceutical segments together drive the biopharma buffer market in the region. Europe is in the 2nd position in the regional market for the biopharma buffer market. Increasing demand for the discovery of novel vaccines and immunotherapy to treat infectious and autoimmune disease further propel the biopharma buffer market growth in the region. The Asia Pacific is anticipated to register comfortable market growth during the forecast period on account of developing healthcare infrastructure and flourishing drug formulation and development market.

Biopharmaceutical companies actively engaged in the manufacturing of biopharma buffer are Merck KGaA.,Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., Lonza, Becton Dickinson and Company, Promega Corporation, GE Healthcare, ANGUS Chemical Company, Takara Bio, Inc., and VWR International, LLC.

Market Key Takeaways:

  • Significant increase in the drug development activities across the life science industry
  • Rising prevalence of infectious disease creates a burgeoning requirement of novel drug discovery and vaccine development to curb its fatality
  • The constant rise in the academic research institutes worldwide to promote breakthrough research and technology to cater to the medical needs of mankind

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Neonatal Enteral Feeding Devices Market Is Expected to Grow at a CAGR of 6.3% from 2020 to 2027

Medical device manufactures are using materials for neonatal enteral feeding which exhibits resilience to a wide range of pH, excellent tensile strength, gentle to body tissue and does not favor the growth of any bacteria over its surface.

Feeding pumps are reigning the product type segment for neonatal infants enteral feeding devices market. The feeding of human milk is very critical in neonates who are ill and very frail to be breastfed. The continuous feeding of milk might lose fat and protein content and hence the feeding pumps are necessary to avoid nutrition depletion by providing rotating pole clamps, flow rate accuracy, interlocking connectors to prevent the accidental pull apart, and bolus protection. Feeding tubes will be registering marvelous market growth during the forecast period on account of the increasing number of neonates born with very low birth weight worldwide. Polyurethane tubes are preferred over PVC and silicone tubes due to its ergonomic features such as soft at body temperature, relatively thin wall which does not collapse when suction is applied and has a large interior diameter and small exterior diameter.

Browse the full report Neonatal Enteral Feeding Devices Market  – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/neonatal-infants-enteral-feeding-devices-market

Hospitals & clinics are presently leading the end-user segment for neonatal infants enteral feeding devices market. In the developed countries the neonates are born in the government-funded hospital and clinics which have the provision of neonatal intensive care units to provide medical assistance to sick neonates. Ambulatory surgical centers will be registering rampant market growth in the near future chiefly due to its ability to provide neonatal intensive care services for neonates born in remote locations.

North America is currently spearheading the geography segment for neonatal infants enteral feeding devices market growth. A constant rise in the number of neonates being exposed to nosocomial infection determines the market growth in the region. According to the latest recent findings provided by the Center for Disease Control and Prevention (CDC), the deaths per 100,000 live births in the U.S. are 566.2 each year. Additionally, the presence of major players such as Cardinal Health, Inc., Becton Dickinson, and Company, Atlanta Biomedical Corporation, Moog, Inc., etc. further accentuate the market growth in the region. Europe is the second-largest regional market, on account of the supportive regulatory environment provided by the European Medical Agency for the sale and distribution of neonatal enteral feeding devices. The Asia Pacific is anticipated to be the fastest-growing regional segment during the forecast period. A significant increase in the number of preterm births reported each year drives the neonatal enteral feeding devices market.

Medical device manufacturers actively engaged in the production of neonatal enteral feeding devices are Cardinal Health, Inc., Vygon SA., Becton Dickinson and Company., Atlanta Biomedical Corporation., Moog, Inc., DEGANIA SILICONE, LTD., Avanos Medical Devices., Canafusion., GBUK Group Ltd., and CAIR LGL.

Key Market Movements:

  • Significant increase in the number of preterm births and neonates born with very low body weights worldwide
  • A constant rise in the neonates exposed to nosocomial infection accentuates the enteral feeding devices market growth
  • Technological advancement in the neonatal enteral feeding devices will further propel the market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Outlook Market Report Market Reports

Global Favipiravir Market is expected to grow at a CAGR of 4.8% from 2020 to 2027

Favipiravir functions as a prodrug which undergoes ribosylation and phosphorylation to get converted into the active favipiravir-RTP which inhibits RNA dependent RNA polymerase to prevent the transcription and replication of the viral genome.

Influenza is currently representing the largest market share in the treatment segment for favipiravir market. As per the latest statistics provided by the World Health Organization (WHO), approximately 650,000 deaths are reported with influenza infection and it is estimated to cause severe illness in 3 to 5 million people worldwide. Countries having cool temperate climates are teeming grounds for influenza B viral infection whereas, tropical climate supports the spread of influenza A viral infection. Lack of self-hygiene and poor vaccination programs are the primary factors for the spread of influenza infection in developing countries. Ebola is a deadly viral infection affecting humans and non-human primates, the four species which are known for its infections in humans are Sudan, Zaire, Bundibugyo, and Taï of which the Zaire species is the most lethal. The mortality rate associated with Ebola is ranging from 22% to 88% and the onset of the disease is sudden and intense, transmitted rapidly in human beings by contact with bodily fluids. Currently, the entire globe is under the threat of COVID-19 infection, China being the epicenter, huge mortality rate and lack of vaccine increases the demand for favipiravir as a promising drug for the treatment of COVID-19 infection in the near future.

Browse the full report Favipiravir Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/favipiravir-market

Hospital pharmacy is leading the distribution channel segment for the favipiravir market. It is imperative to take antiviral drugs under medical supervision as non-adherence to prescription might result in toxicity and severe drug-related side effects. Hospital pharmacist is critical in adjusting the dose regimen in accordance with a doctor’s prescription. Retail pharmacy gaining huge market traction in the developing regions on account of a significant increase in viral infections in slum areas and the ability to cater to medicinal requirements of patients residing in far-flung remote areas.

The Asia Pacific is presently dominating the geography segment for the favipiravir market. The chief attribute responsible for its market dominance is the significant rise in the incidence rate of influenza A. viral infection in the South East Asian region. The recurrent occurrence of seasonal influenza is due to factors such as the tropical climate, high humidity, and monsoon climate. Additionally, the domicile of major players such as Fujifilm Toyama Chemical Co., Ltd, Zhejiang Hisun Pharmaceutical Co., Ltd., Cipla Limited, Beximco Pharmaceuticals Limited, etc further propels the market growth in the region. Europe is in the Northern Hemisphere with a cool temperate climate which is teeming grounds for the rampant spread of influenza B. viral infection during the winter season. Central Africa has the most reported cases of Ebola infection in the world which increases the demand for the favipiravir market in the region. North America is anticipated to register magnificent market growth in the near future owing to the proactive role adopted by the healthcare agencies in conducting clinical trials to study the therapeutic efficacy and safety for the treatment of people suffering from COVID-19 infection.

Biopharmaceutical companies actively engaged in the manufacturing of favipiravir are Fujifilm Toyama Chemical Co., Ltd., Zhejiang Hisun Pharmaceutical Co., Ltd., Cipla Limited., Lasa Supergenerics Limited., ChemRar Group., Beximco Pharmaceuticals Limited., Beacon Pharmaceuticals., Clinigen Group and Medivector, Inc.

Market Key Takeaways:

  • Significant increase in the number of RNA virus infection such as influenza, ebola, etc. throughout the globe
  • Positive results obtained from clinical trial studies pertaining to the therapeutic efficacy and safety of favipiravir for the treatment of COVID-19
  • The supportive regulatory environment provided by the global healthcare agencies for adopting favipiravir in the treatment of COVID-19

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Report Market Reports

Global Brain Sensing Headband Market Is Expected To Grow At A CAGR Of 9.2% From 2020 To 2027

The brain-sensing headset has a wireless connection with the smartphones to enable a digital translation of various neuronal activities. Rising prevalence of neuronal disorders, increasing geriatric population and a significant rise in the technology pertaining to brain-computer interface together drive the brain sensing headbands market. The major obstacle associated with the market is the exorbitant cost of the wireless brain-sensing headbands and monitoring software.

Sleep monitoring is spearheading the application segment for brain-sensing headbands market. As per the research citings brought forward by the National Sleep Foundation (NFS), approximately 30% of the world population is suffering from insomnia. Brain sensing headbands are vital in understanding the sleep patterns in an individual and ensures in maintaining normal circadian rhythm. Electroencephalograms (EEG) are keen to register the fastest growth in the application segment during the forecast period owing to its huge attraction from the IT healthcare segment to understand the various neuronal activities related to EEG patterns to aid the neuropsychiatrist to determine a treatment regimen.

Browse the full report Brain Sensing Headband Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/brain-sensing-headband-market

Personal care is currently dominating the end-user segment for the brain sensing headbands market. The excellent ergonomic features such as wireless sensors, user-friendly interface, ease of monitoring, and the ability to track important parameters pertaining to mental health determine the demand for brain-sensing headbands for personal care. It is anticipated that research institutes will gain huge traction for brain-sensing headbands for developing software for the accurate interpretation of different EEG patterns pertaining to neuronal disorders such as epilepsy, migraine, multiple sclerosis, etc.

North America is presently leading the geography segment for the brain sensing headband market. According to the latest statistics brought forward by the American Association of Neurological Surgeons, approximately 1.7 million United States citizens are suffering from traumatic brain injuries causing epilepsy, migraine, and insomnia. Domicile of major companies such as Interaxon, Inc., NeuroSky, EMOTIV, Inc., further consolidates the market growth in the region. Europe stood in the second position in the regional segment primarily due to strategic collaboration between IT-healthcare companies and academic research institutes to develop wireless brain-sensing headbands. Furthermore, increasing geriatric population is expected to increase the number of cases of other neurological conditions such as dementia, Alzheimer’s, Parkinson’s, etc. will increase the demand for brain-sensing headbands. The Asia Pacific is set to witness comfortable market growth owing to the significant rise in the IT-healthcare segment and the increasing adoption of wearable health gadgets among health enthusiasts in the region.

IT healthcare companies engaged in the development of brain-sensing headbands are Interaxon, Inc., Spire Health, NeuroSky, NextMind, Versus, Quantum Technology, Nia Therapeutics, EMOTIV, Inc., Evolent Health, Inc., and Advanced Brain Monitoring, Inc.

Market Key Takeaways:

  • Significant rise in the neuronal disorders worldwide
  • Revolutionary development in the IT healthcare segment for developing wireless brain sensing headband and monitoring software
  • Increasing demand for wearable sensors and gadgets among health enthusiast throughout the globe

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Report Market Reports

Global Betahistine Market is expected to grow at a CAGR of 3.9% from 2020 to 2027

As per the latest statistics provided by the Hearing Health Foundation (HHF), the incidence rate of Ménière’s disease is 12 per 1000 people throughout the globe. Additionally, the orphan drug status awarded to betahistine for the treatment of PWS-linked obesity will provide a positive impetus to the betahistine market growth.

Ménière’s disease is the clear leader in the treatment segment for the betahistine market. According to the latest research findings presented by the Hearing Health Foundation approximately 45,000 to 60,000 cases of Ménière’s Disease are diagnosed each year. The disease prognosis is unilateral initially and later it progresses to bilateral, 15% of the patients report the clinical manifestations in both the ears in the later stage of life, the onset age are 20 to 50 years of age and it affects equally in the men and women population. Benign paroxysmal positional vertigo (BPPV) is set to register steady market growth in the near future owing to the significant increase in the clinical manifestation of vertigo and dizziness among the adult population. According to research findings provided by the Oxford University Press vertigo affects about 1 in 3 adults every year.

Browse the full report Betahistine Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/betahistine-market

Hospital pharmacy is spearheading the distribution channel segment for the betahistine market. Betahistine is a potent antihistaminic drug that needs to be taken under medical supervision in order to prevent the occurrence of any drug-related side effects. Hospital pharmacist ensures accurate dose compounding as per physician’s prescription. Retail pharmacy is anticipated to be the fastest-growing distribution channel segment on account of the availability of generic versions of betahistine drug formulation at discounted prices.

North America is currently leading the geography segment for the betahistine market. According to the American Academy of Otolaryngology (AAO), approximately 615,000 people in the United States suffer from Ménière’s disease. Affordable reimbursement scenario further accentuates the betahistine market growth in the region. Europe stood 2nd in the regional segment for the betahistine market. According to the recent statistics posted by the World Health Organization (WHO), the annual incidence rate of vertigo associated with benign paroxysmal positional vertigo (BPPV) is 48.3% in the European Union region. Furthermore, the supportive regulatory environment provided by the European Medical Agency (EMA) pertaining to the sale and distribution of betahistine further propels the market growth in the region. The Asia Pacific will showcase rampant market growth during the forecast period on account of the rising prevalence of vertigo migraine across all age groups and the presence of a well-established generic drug market.

Pharmaceutical companies actively engaged in the manufacturing of betahistine are Auro Pharma, Inc., Sanis Health, Inc., BGP Pharma ULC, Eurofarma, Teva Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd, Grünenthal, Mylan Labs Ltd, Sun Pharma Laboratories Ltd, and Eisai Co., Ltd.

Market Key Takeaways:

  • Significant increase in the number of patients suffering from Meniere’s disease and benign paroxysmal positional vertigo
  • Orphan drug status awarded to betahistine for the treatment of PWS-linked obesity will further accentuate the market growth
  • Affordable reimbursement scenario for the betahistine drug formulations will further propel the market growth during the forecast period

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Report Market Reports

Global Functional Dyspepsia Drug Market Is Expected to Grow at a CAGR of 3.0% from 2020 to 2027

Functional dyspepsia has an annual incidence rate of 9 to 10% worldwide, the recent definition as postulated from the Rome I and II consensus committees is that dyspepsia is considered as discomfort and pain encountered in the upper abdomen region. Further clinical investigation has revealed a high preponderance of functional dyspepsia in the female population in comparison to the male population.

Acid suppressant therapy is spearheading the treatment regimen segment for the functional dyspepsia drug market. Omeprazole, lansoprazole, pantoprazole, etc. need to be taken 30 minutes prior to any meal in order to subdue the excessive acids produced by the proton pumps present in the stomach mucosa. Prokinetic agents such as metoclopramide and domperidone are frequently employed to digestive tract motility by increasing the lower esophageal sphincter pressure to facilitate gastric emptying and antropyloric motility. Antidepressants are anticipated to register rampant market growth in the near future owing to its ability to relieve anxiety and stress-related indigestion with improved gastric accommodation and postprandial symptoms.

Browse the full report Functional Dyspepsia Drug Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/functional-dyspepsia-drug-market

Hospital pharmacy is presently leading the distribution channel segment for the functional dyspepsia market. Precise compounding of functional dyspepsia treatment drugs in accordance with a physician’s prescription by the hospital pharmacist is mandatory to negate the occurrence of any drug-related adverse events. Retail pharmacy is gaining tremendous demand as a sales channel in the developing regions on account of established generic drugs market and the ability to cater to medicines at cheaper prices.

North America is currently spearheading the geography segment for the functional dyspepsia drug market. A significant increase in dyspepsia primarily drives market growth in the region. As per the latest research citings presented by the National Institute of Health (NIH), 24% of the population in the United States suffer from heartburn at least once a month. The causative agents associated with functional dyspepsia in the region are increasing consumption of caffeinated beverages, alcohol, tobacco, junk food, etc. Europe is in the 2nd place in the regional segment for the functional dyspepsia drug market. Affordable reimbursement scenario and supportive regulatory environment provided by the European Medical Agency (EMA), for the sale and distribution of functional dyspepsia drugs together, accentuate the market growth in the region. The Asia Pacific is anticipated to be the fastest-growing segment during the forecast period on account of the spicy diet, a growing inclination for carbonated drinks, etc. It provides a lucrative market opportunity for the western giants to establish retail outlets in the Asia Pacific region.

Pharmaceutical manufacturers actively engaged in the production of functional dyspepsia drugs are Sandoz, Inc., Aurohealth LLC., Cadila Healthcare Ltd., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline, Plc., Mylan Pharmaceutical Industries Ltd., Cipla Limited., Sanofi Aventis., Accord Healthcare, and Bayer AG.

Market Key Takeaways:

  • A constant rise in the number of the adult population suffering from functional dyspepsia worldwide
  • Effective diagnosis of the dyspepsia type followed by effective implementation of treatment guidelines to accentuate the market growth
  • Affordable reimbursement scenario for the drugs employed for the treatment of functional dyspepsia will further propel the market growth.

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Report Market Reports

Global Urokinase Market Is Expected To Grow At A CAGR Of 3.6% From 2020 To 2027

Urokinase is a serine protease that causes the breaking of plasminogen in order to form active fibrinolytic protease. It is imperative to consult a patient regarding the associated risk of bleeding, infusion reactions, anaphylaxis, and cholesterol embolization.

Pulmonary embolism is reigning the treatment segment for the urokinase market. As per the latest statistics provided by the National Institute of Health (NIH), the incidence of pulmonary embolism is estimated to be 60 to 70 per 100,000 people throughout the globe. Formation of a blood clot in deep veins of the legs which eventually travels to the lungs and blocks the pulmonary artery. Occluded catheters are keen to register excellent market growth in the near future owing to the constant rise in the number of catheters guided surgical procedures opted throughout the globe. Occlusions occur in 25% cases of central venous access devices, when the catheter is introduced into the body then there is an accumulation of fibrin at the catheter tip as a natural defense mechanism against the foreign body. Multilayers of fibrin begin to form at the tip or surrounding the catheter where occlusion might take place.

Browse the full report Urokinase Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/urokinase-market

Hospitals & clinics are dominating the end-user segment for the urokinase market. Significant increase in the number of hospitalized patients opting to undergo catheter guided surgical procedures for the treatment of cardiovascular disorders related to artery and vein blockage. Ambulatory surgical centers have gained strong grounds in the end-user segment on account of its ability to serve patients suffering from deep vein thrombosis residing in remote locations.

North America is currently leading the geography segment for the urokinase market. As per the latest statistics provided by the Center for Disease Control and Prevention (CDC), the estimated incidence of pulmonary embolism is 71 to 117 per 100,000annually. The existence of well-developed healthcare infrastructure and favorable reimbursement scenario for urokinase together accentuates its market growth in the region. Europe is considered as the second-largest market in the regional segment for urokinase market. As per the statistics provided by the European Commission report, annually approximately 465,715 people are suffering from venous thromboembolism in the European Union region. Furthermore the supportive regulatory environment provided by the European Medical Agency for the sale and distribution of urokinase further propels the market growth in the region. Asia Pacific is anticipated to register magnificent market growth during the forecast period on account of the rising prevalence of patients suffering from the peripheral intravascular thrombus and constant rise in the medical tourism industry.

Biopharmaceutical companies actively engaged in the production of urokinase are Microbix Biosystems, Inc., Cadila Healthcare Ltd, Wanhua Biochem Products Co., Ltd, Jiangxi Haoran Bio-Pharma Co., Ltd, Medac GmbH, EUMEDICA S.A, Syner-Med (Pharmaceutical Products) Ltd., Livzon Pharmaceutical Group, Inc., Taiwan Green Cross Co, Ltd., and Sedico.

Market Key Takeaways:

  • Significant increase in the number of new cases reported pertaining to pulmonary embolism
  • A constant rise in the number of catheter guided surgical procedures performed worldwide
  • Affordable reimbursement scenario for the use of urokinase as a thrombolytic agent

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Albendazole Market Is Expected to Grow at a CAGR of 3.6% from 2020 to 2027

Albendazole is a potent anthelmintic that is used for the treatment of parasitic worm infestation occurring in both the children and the adult population. It needs to be taken under medical supervision in order to prevent severe drug-related adverse events such as headache, nausea, vomiting, abdominal pains, etc.

Currently, the soil-transmitted helminths infection is reigning the clinical application segment for the albendazole market. According to the latest research citings presented by the Center for Disease Control and Prevention (CDC), approximately 2 billion people throughout the globe are suffering from soil-transmitted helminths infection. The different types of soil-transmitted helminths infection occurring worldwide are Ascaris, whipworm, and hookworm, which usually occur in the countries favoring tropical climate. Schistosomiasis will be registering excellent market growth in the near future owing to the key factor such as a significant increase in water population in developing countries due to rapid urbanization. It is also called bilharzia, usually found in the contaminated waters, the most common infections caused in human beings are due to S. japonicum, S. haematobium and S. mansoni etc. According to the latest research citings provided by the World Health Organization (WHO), approximately 290.8 million people worldwide received treatment for schistosomiasis in 2018.

Browse the full report Albendazole Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/albendazole-market

Hospital pharmacy is presently leading the distribution channel segment for the albendazole market. The drug posology for albendazole varies for children and adult, hence it becomes imperative for accurate drug compounding by the hospital pharmacist to prevent the occurrence of any side effects due to drug overdose. Retail pharmacy is anticipated to be the fastest-growing distribution channel segment on account of the existence of a well-developed generic drug market and the ability to provide cheap medicines to patients residing in remote locations.

Asia Pacific is presently dominating the geography segment for the albendazole market. Significant increase in the number of children and women suffering from schistosomiasis infection primarily drives the albendazole market growth in the region. The moist and humid climate present in the south Asian countries favors the spread of neglected tropical diseases. Presence of major players in the region such as Cadila Healthcare Limited, Cipla Limited., GlaxoSmithKline, Plc. Dr. Reddys Laboratories Ltd. etc further propel the albendazole market growth in the region. Latin America is in the second position in the regional segment for the albendazole market. The rising prevalence of genital schistosomiasis infection in the women population determines the albendazole market growth in the region. North America is expected to record rampant market growth during the forecast period. The supportive regulatory environment provided by the USFDA and favorable reimbursement scenario together drive the albendazole market growth in the region.

Pharmaceutical manufacturers actively engaged in the production of albendazole are Cadila Healthcare Limited, Actavis Pharma, Inc., Cipla Limited, GlaxoSmithKline, Plc. Genfar S.A., Dr. Reddys Laboratories Ltd., Beximco Pharmaceuticals Ltd., Unison Laboratories Co Ltd, MEDLEY GENERICOS, and Mankind Pharma.

Market Key Takeaways:

  • Rising prevalence of soli-transmitted helminths infection in tropical countries
  • Significant increase in the number of children and women suffering from schistosomiasis infection worldwide
  • Effective implementation of treatment guidelines pertaining to helminths infection will further accentuate the albendazole market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Ear Bandage Market is expected to grow at a CAGR of 5.0% from 2020 to 2027

Ear bandages are manufactured with the intention to serve a dual purpose which is complete wound closure and subsequent wound healing. The parameters which determine its medical utility are the high retention time, waterproofing, and capability to cover the entire lacerated area of the ear. According to the World Health Organization (WHO), annually more than 50 million people throughout the world suffer from motor vehicle accidents eventually suffering from ear, nose, and cranial laceration. Increasing human-pet adoption will further increase the market demand for the ear bandages.

In the present scenario, one-sided ear bandages are leading the product segment for the ear bandages market. It is the bandage of the first choice for domestic accidents, ornamental ear piercing which often results in an ear infection. The positive ergonomic features associated with the ear bandages such as latex-free material, flexible design to cover complete wound area, and high retention time of the bandage adhesives determine the one-sided ear bandages market growth. Double-sided ear bandages will register sturdy market growth during the forecast period on account of its importance in otoplasty surgical procedures, ear lacerations obtained due to contact sports, and frequent roadside accidents.

Browse the full report Ear Bandage Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/ear-bandages-market

The human application segment is spearheading the ear bandages market. Rising prevalence of roadside accidents, frequent domestic accidents resulting in severe ear laceration increases the demand for ear bandages market. Growing inclination towards contact sports such as boxing and martial arts further increase the demand for ear bandages to tend human ear wounds and lacerations. Animal application segment will register rampant market growth in the near future owing to the increasing pet adoption in developed countries and a significant rise in animal cruelty in the developing regions determines the ear bandages application for tending animal ear wounds and lacerations.

North America is currently holding the largest market share in the geography segment for the ear bandage market. As per the research citings brought forward by the Center for Disease Control and Prevention (CDC), 1 in 7 people in the United States do not wear a seat belt while driving and often result in suffering from severe facial trauma and ear laceration. The presence of emergency medical services further propels the ear bandages market in the region. In Europe, the rising prevalence of household facial accidents and ornamental ear-piercing consolidates the ear bandages market in the region. The Asia Pacific is anticipated to register comfortable market growth owing to the flourishing otoplasty market. An increasing number of cases pertaining to domestic violence further bolsters the ear bandages market growth in the Asia Pacific region.

Pharmaceutical companies actively engaged in the manufacturing of ear bandages are NIPPON EIZAI, SPIGGLE & THEIS Medizintechnik GmbH, Bettering International, Robinson Healthcare, First Aid Bandage Company, Changqing, PREVIS, Phoenix Design Solutions LLC, Pikdare S.r.l. and Lanyuan Healthcare.

Market Key Takeaways:

  • Increasing cases of roadside accidents resulting in eat laceration and facial trauma
  • Technological advancement in the manufacturing of ear bandages ensuring optimum wound closure and prevention of infection
  • The supportive regulatory environment provided by healthcare agencies facilitates its early adoption for wound treatment

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Report Market Reports

Global Sphenoidal Electrodes Market Is Expected To Grow At A CAGR Of 6.9% From 2020 To 2027

Sphenoidal electrodes are crucial in catering to a non-invasive method in locating the epileptic foci responsible for the occurrence of temporal lobe epilepsy. It is inserted in anesthetic conditions, a sterile environment in the zygomatic arch through the mandibular notch using a lumbar puncture needle to record the electroencephalogram (EEG) associated with temporal lobe epilepsy. Rising prevalence of epilepsy in developing regions and technological advancement in the sphenoidal electrodes together determine its market growth.

Stainless steel sphenoidal electrodes are being used since the late 1970s in the electroencephalogram of temporal lobe epilepsy. It was a material of choice owing to its physical durability and good biocompatibility and low cost. Platinum sphenoidal electrodes are presently dominating the product segment for the sphenoidal electrodes market. The major ergonomic features which increased its popularity among the neuropsychiatric surgeons for performing EEG were its low resistance conductance to increase the EEG signal transfer and its non-ferromagnetic nature making it compatible with MRI to procure good signals. The disadvantages associated with the platinum electrodes are its high cost and polarizability. The silver/silver chloride electrode is gaining huge demand on account of its ability to achieve low baseline drift low polarization and good signal quality while conducting an electroencephalogram (EEG).

Browse the full report Sphenoidal Electrodes Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/sphenoidal-electrodes-market

Hospitals and clinics are spearheading the end-user segment for the sphenoidal electrodes market. The patients suffering from frequent epileptic seizures are kept under medical supervision in the neuropsychiatric hospitals & clinics. An electroencephalogram (EEG) is performed in order to determine the treatment regimen or surgical procedure for the treatment of epilepsy. Research institutes have gained tremendous demand owing to the huge financial funding approved by the government healthcare agencies to study the different possible patterns of epileptic seizures and determine the treatment regimen accordingly.

In the present scenario North America is dominating the geography segment for the sphenoidal electrodes market. As per the latest statistics provided by the Center for Disease Control and Prevention (CDC), approximately 3.4 million U.S. citizens are suffering from epilepsy comprising 3 million adults and 470,000 children. The presence of well-equipped neuropsychiatric hospitals & clinics further determines the sphenoidal electrodes market growth in the region. Europe stands at the 2nd position in the geography segment for the sphenoidal electrodes market. Rising prevalence of temporal lobe epilepsy in the adult population and strategic collaboration between research institutes and medical device manufacturers determine the market growth in the European region. Asia Pacific is set to register rampant market growth during the forecast period owing to the rising public health awareness pertaining to the useful application of EEG in conducting the surgical procedures for epilepsy treatment.

Medical device manufacturers actively engaged in the production of sphenoidal electrodes are Axis Healthcare, GVB-geliMED GmbH, PMT Corporation, Ad-Tech Medical, Cleveland Clinic, and Integra LifeSciences Corporation and others.

Key Market Movements:

  • Rising prevalence of temporal lobe epilepsy worldwide
  • Technological advancement in the development of sphenoidal electrodes
  • Increasing public health awareness pertaining to performing EEG for conducting the surgical procedure for the treatment of epilepsy

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Metronidazole Market is expected to grow at a CAGR of 2.5% from 2020 to 2027

Metronidazole belongs to the nitroimidazole class of antibiotics which is used for the treatment of giardiasis, trichomoniasis, amoebiasis, and other parasitic infections. After the administration of metronidazole, it enters the cells by passive diffusion, ferredoxin reduces it to nitro radicals which selectively blocks the nucleic acid synthesis of microorganisms. Bacterial vaginosis is dominating the treatment segment for the metronidazole market. As per the statistics provided by the World Health Organization (WHO), approximately 84% of the women population suffering from bacterial vaginosis do not show any early symptoms. Major causative agents are sexually transmitted diseases, such as syphilis, gonorrhea, AIDS, chlamydia, herpes simplex, etc. Rosacea is estimated to register excellent market growth during the forecast period owing to the constant rise of rosacea in the Caucasian population worldwide. According to the research citings presented by the European Society for Dermatological Research (ESDR), approximately 400 million people worldwide are suffering from rosacea. Intermittent exposure to sunburn and extreme cold weather causes the disease prognosis of rosacea which is further aggravated by the consumption of tobacco and alcohol. Browse the full report Metronidazole Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/metronidazole-market Hospital pharmacy is reigning the distribution channel segment for the metronidazole market. Accuratedispensingof metronidazole is essential to avoid any drug-related side effects. Hospital pharmacist ensures precise compounding of metronidazole drug formulation in consonance with the physicians prescription. Retail pharmacy is gaining huge demand in developing countries in order to cater to the medicinal needs of a huge population base and availability of generic drugs at attractive prices. North America is spearheading market share in the geography segment for the metronidazole market. Rising prevalence of bacterial vaginosis in women population aged 14 to 49 primarily drives the metronidazole market growth in the region. As per the latest statistics provided by the Center for Disease Control and Prevention (CDC), approximately 29.2% of women population in the United States are suffering from bacterial vaginosis. Affordable reimbursement scenario for different drug formulation of metronidazole accentuates its market growth in the region. Europe represents the 2nd largest market in the regional segment for the metronidazole market. According to the latest research information brought forward by the European Commission the prevalence rate of rosacea is ranging from 9 to 22%, it is highly prevalent in Celtic and German people and has a high incidence rate in the female population in comparison to male. Asia Pacific is going to register magnificent market growth during the forecast period on account of the rising prevalence of gastrointestinal parasitic infection across all age groups and the existence of a well-developed generic drug market in the region. Pharmaceutical companies actively engaged in the manufacturing of metronidazole drug formulation arePfizer, Inc., Lupin Ltd., Auro Pharma, Inc., Viona Pharmaceuticals, Inc., Unichem Pharmaceuticals, Inc., Baxter Healthcare Corporation, Fresenius Kabi AG, Sandoz, Inc., Galderma S.A., and Teva Pharmaceutical Industries Ltd. Market Key Takeaways:
  • Constant rise in the bacterial and parasitic infection worldwide
  • Constant rise in the generic drug market in the developing regions accentuates its market growth
  • Affordable reimbursement scenario for the different metronidazole drug formulation employed in the treatment of bacterial vaginosis, rosacea, amoebiasis, etc.
About Atlantic Market Research Atlantic Market Research is the largest provider of market research and consulting services. Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth. Contact: Mr. Trevor Wilson Atlantic Market Research 911 Central Ave #268 Albany, NY 12206, USA Website: https://www.atlanticmarketresearch.com Email: [email protected]
Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Manidipine Hydrochloride Market Is Expected to Grow at a CAGR of 3.5% from 2020 to 2027

Manidipine hydrochloride causes vasodilation in the kidney region and an increase in natriuresis to produce its antihypertensive effect by reducing the blood volume. Manidipine significantly binds and then slowly dissociates from the T and L type voltage-dependent calcium channels which are present in the smooth muscle of the peripheral vasculature thereby blocking the uptake of extracellular calcium and prevents vasoconstriction.

Moderate hypertension is presently spearheading the clinical application segment for the manidipine hydrochloride market. According to the latest statistics provided by the World Health Organization (WHO), each year hypertension is accountable for 12.8% of the total deaths occurring worldwide. Furthermore, it is estimated that half of the cases suffering from moderate hypertension are subjected to suffer from severe hypertension if accurate first-line therapy is not prescribed by the physicians. Renal protection in type 2 diabetes is anticipated to be registered with sturdy market growth during the forecast period. In patients suffering from preexisting comorbidities such as diabetes and hypertension, there is an 80% chance of developing end-stage kidney disease in the latter part of life.

Browse the full report Manidipine Hydrochloride Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/manidipine-hydrochloride-market

Monotherapy is dominating the treatment regimen segment for the manidipine hydrochloride market. Significant rise in the number of patients suffering from mild to moderate hypertension worldwide primarily drives its market growth. Cardiologist worldwide recommends a dose of 10-20mg once daily for patients suffering from mild to moderate hypertension. Combination therapy has gained prominence in the last 2 decades due to the effective implementation of treatment guidelines pertaining to hypertension management. Delapril 30mg/manidipine 10mg is prescribed for its ability to manage renal complications in type diabetic patients with hypertension.

Europe is presently representing the largest market share in the regional segment for the manidipine hydrochloride market. A constant increase in young adults suffering from moderate hypertension due to increasing consumption of alcohol, tobacco & stressful lifestyle. According to the latest statistics presented by the European Heart Network (EHN), approximately 1.8 million people die annually in the European Union region associated with cardiovascular complications. The presence of well-developed healthcare infrastructure and affordable reimbursement scenario for manidipine hydrochloride drug formulation together drive the market growth in the region. The USFDA has not recommended the use of manidipine hydrochloride in North America. It is expected that the future Asia Pacific will be the fastest-growing regional segment for the manidipine hydrochloride market. A constant rise in geriatric population suffering from end-stage kidney disease & hypertension, and lucrative market opportunities for western giants to establish subsidiaries further accentuate the market growth in the Asia Pacific region.

Pharmaceutical manufacturers actively engaged in the production of manidipine hydrochloride are Chiesi Farmaceutici s.p.a., Takeda Italia SpA, KOSEI PHARMA, Sandoz España (Sandoz Farmacéutica, S.A.), Choseido Pharmaceutical Co., Ltd., Bennett SA, Mylan Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd.

Market Key Takeaways:

  • A constant rise in the number of young adult patients reporting with moderate hypertension worldwide
  • Significant rise in elderly patients suffering from renal complication with preexisting comorbidities such as type 2 diabetes and hypertension
  • Effective implementation in the treatment guidelines pertaining to hypertension management to further accentuate the market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global High Definition Breast Tomosynthesis Market is expected to grow at a CAGR of 13.5% from 2020 to 2027

Breast tissues attain different morphology at different stages of life primarily influenced by the hormonal levels and environmental factors affecting the human body. High definition tomosynthesis is an up-gradation to the earlier versions of digital breast tomosynthesis which is useful in achieving high-resolution images and videos of breast cancer cells and tissue under investigation. Breast tomosynthesis employs a low radiation dose by employing an x-ray tube that moves like an arc achieving breast images from different angles to create multiple data points that can be reconstructed in different ways for effective diagnosis of breast cancer cases.

2D/3D combination systems are presently leading the product segment for high definition breast tomosynthesis market. The major factor responsible for its technical viability among oncologists is its capability to precisely analyze the calcification and no calcification cases of breast cancer which is relatively difficult to analyze by employing either dimensional system. Standalone 3D systems are very crucial in screening breast cancer owing to its excellent ergonomic features such as increased sensitivity and reduced recalls rendering it to effectively diagnose invasive cancer cases and reduction in false-positive cases.

Browse the full report High Definition Breast Tomosynthesis Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/high-definition-breast-tomosynthesis-market

Hospitals are dominating the end-user segment for the high definition breast tomosynthesis market. The primary health care centers are the first point of contact for patients opting for early screening of breast cancer. Government health agencies are providing huge funds for the establishment of well-equipped devices for performing screening of breast cancer. Diagnostic centers have gained tremendous traction in the last decade on account of the availability of a skilled workforce for the operating of sophisticated breast tomosynthesis devices and precise interpretation of images.

North America is holding the largest market share in the geography segment for high definition breast tomosynthesis market. As per the research citings brought forward by the American Cancer Society (ACS) in 2019 in the United States approximately 268,600 new cases of breast cancer were reported among the women population. Existence of key players such as Hologic, Inc., GE Healthcare, Siemens Healthineers further propel the market growth pertaining to high definition breast tomosynthesis in the region. In Europe the number of breast cancer cases among the female population as diagnosed in 2018 was 562,500 according to the statistics of the European Breast Cancer Coalition. The strategic collaboration between academic research institutes and medical device manufacturers for the development of breast tomosynthesis devices. Asia Pacific is set to register impressive growth during the forecast period owing to the increasing public health awareness related to the benefits of early screening in breast cancer and developing healthcare infrastructure.

Medical device manufacturers pioneering in the production of high definition breast tomosynthesis are Siemens Healthineers, GE Healthcare, Fujifilm Corporation, Hologic, Inc., Agfa-Gevaert, IMS GIOTTO S.p.A., PLANMED OY., Dexela Ltd., Carestream Health and Metaltronica S.p.A.

Market Key Takeaways:

  • Rising prevalence of breast cancer worldwide
  • Technological advancement and up gradation in the breast tomosynthesis devices to achieve high-resolution images
  • Strategic collaboration between academic research institutes and medical device manufactures to develop high definition breast tomosynthesis devices

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Delapril Hydrochloride Market Is Expected to Grow at a CAGR of 2.3% from 2020 to 2027

Delapril hydrochloride is a prodrug that gets converted to active metabolite 5-hydroxy delapril diacid which exerts its antihypertensive activity by preventing the conversion of angiotensin 1 to angiotensin 2, thereby enhancing the excretion of sodium and hence causing an increase in water outflow.

Hypertension is presently spearheading the clinical application segment for the delapril hydrochloride market. As per the latest statistics provided by the World Health Organization (WHO), approximately two-thirds of the global cases of hypertension are occurring in low and middle-income countries. It is considered a serious medical condition that increases the risk of damaging internal organs such as the brain, kidney, heart, lungs, etc. Further research studies convey that 1 in 4 men and 1 in 5 women suffer from hypertension worldwide. Type 2 diabetes with hypertension is anticipated to be the fastest-growing clinical application segment for the delapril hydrochloride market. As per the latest research citings presented by the American Diabetes Association (ADA), the coexistence of type 2 diabetes and hypertension increases 4 fold risk of developing heart stroke and end-stage kidney disease in a later stage of life.

Browse the full report Delapril Hydrochloride Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/delapril-hydrochloride-market

Combination therapy is the largest and fastest segment in the delapril hydrochloride market. Delapril is used in combination with manidipine and indapamide for the effective management of hypertension. Delapril 30 mg /indapamide 2.5 mg is beneficial in hypertensive patients who are at greater risk of suffering from a cerebrovascular stroke in later stages of life. The combination of manidipine 10mg/delapril 30mg is prescribed for managing hypertension in type 2 diabetic patients owing to its renoprotective properties. Monotherapy of delapril is currently used in a few countries in the European countries such as Italy, Spain, and Germany, etc. owing to its ability to reduce the mortality rate associated with hypertension in the geriatric population.

Europe is presently dominating the geography segment for the delapril hydrochloride market. The rising prevalence of hypertension in the younger population in the European Union region primarily drives its market growth. The major causative agents for the occurrence of hypertension are obesity, sedentary lifestyle, unhealthy diet, stress, etc. As per the latest research citings presented by the European Heart Network (EHN) cardiovascular diseases are responsible for 45% of all the deaths in the European region. Affordable reimbursement scenario and favorable regulatory environment provided by the European Medical Agency (EMA), for the manufacturing and sale of delapril hydrochloride further accentuates its market growth in the region. Delapril hydrochloride is not available in North America. Asia Pacific is expected to register rampant market growth during the forecast period. A significant increase in the elderly population type 2 diabetes with hypertension drives the delapril hydrochloride market growth in the region.

Pharmaceutical manufacturers actively engaged in the production of delapril hydrochloride are Chiesi Farmaceutici s.p.a., Promedica Srl, Tokyo Chemical Industry Co., Ltd, Glentham Life Sciences Ltd, LGM Pharma, IWAKI SEIYAKU CO., LTD., Merck KGaA., and MASTER PHARMA Srl.

Key Market Movements:

  • Significant increase in the early onset of hypertension in young adult population worldwide
  • A constant rise in the number of type 2 diabetic patients suffering from hypertension
  • Supportive regulatory environment provided by the global healthcare agencies for the monotherapy and combination therapy of delapril hydrochloride throughout the globe

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Medicinal Mushroom Extracts Market is expected to grow at a CAGR of 9.3% from 2020 to 2027

Medicinal mushrooms are fungal organism which is used as a nutritional supplement and healthy food in daily diet. Rising prevalence of lifestyle disorders and rising public health awareness together drive the medicinal mushroom extracts market growth.

Reishi medicinal mushroom is presently leading the type segment for the medicinal mushroom extract market. It is being used by the royal families since ages for its ability to increase longevity & antiageing properties and hence known as the mushroom of immortality. Reishi comprises ganoderic acid which is critical in reducing high blood pressure and cholesterol levels. Reishi also possesses important properties such as antiviral, antibacterial, etc. and is essential in boosting the immune system. The Chaga medicinal mushroom will be the fastest-growing type segment during the forecast period on account of its immunomodulation properties by stimulating the production of antibodies to fight the invading virus and pathogens. Diligent research has led to the conclusion that it is beneficial in treating autoimmune diseases such as psoriasis, rheumatoid arthritis, etc.

Browse the full report Medicinal Mushroom Extracts Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/medicinal-mushroom-extracts-market

Immunity enhancers are spearheading the clinical application segment for the medicinal mushroom extracts market. As per the World Bank report in 2017, the global healthcare burden associated with communicable disease and nutritional deficiency was 28% due to low immunity in infected patients. Medicinal mushrooms are vital in enhancing immunity by stimulating lymphocytes, cytokines, macrophages, etc. Anticancer clinical application will be showcasing comfortable market growth in the near future owing to the rising prevalence of cancer worldwide. Pharmacological active compounds such as lectins, schizophyllan, lentinan, active hexose correlated compounds, etc. have proved beneficial in the treatment of various cancers such as breast, cervical, colorectal, skin, etc.

North America is the clear leader in the geography segment for the medicinal mushroom extracts market. The rising prevalence of cancer significantly increases the demand for medicinal mushroom extracts in the North American region. As per the latest information provided by the American Cancer Society (ACS), in 2019 approximately 140,690 new cases of cancer were reported in the United States. Rising public health awareness and increasing inclination for the adoption of medicinal mushroom extracts as a nutraceutical supplement further consolidates the market growth in the region. Europe stood second in the regional segment for the medicinal mushroom extracts market. The constant increase in viral infections on account of compromised immunity determines the medicinal mushroom extracts market growth in the region. Asia Pacific is going to be the fastest-growing regional segment on account of the significant increase in the geriatric population suffering from autoimmune diseases.

Nutraceutical companies actively engaged in the provision of medicinal mushroom extracts areNammex, Amax NutraSource, Inc., Oriveda BV, Bio-Botanica, Inc., Nutra Green Biotechnology Co., Ltd., Yuikiguni Maitake Corp., Xian Yuensun Biological Technology Co., Ltd., Nyishar, Hokkaido Reishi Co. Ltd., and Aloha Medicinals, Inc.

Market Key Takeaways:

  • Constant rise in chronic lifestyle disease worldwide
  • Rising public health awareness and growing inclination pertaining to the adoption of medicinal mushroom extracts as a dietary supplement
  • Systematic scientific verification of active compounds present in the medicinal compounds will further increase the demand for medicinal mushroom extracts in Lifesciences industry

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Hydroxycarbamide Market is expected to grow at a CAGR of 2.2% from 2020 to 2027

According to the latest statistics presented by the World Health Organization (WHO), each year approximately 300,000 infants are born with sickle cell anemia. Sickle cell disease is most commonly encountered in people belonging to the Middle East, Sub Saharan Africa, and South Asia region.

Sickle cell disease is ruling the application segment for the hydroxycarbamide market. As per the research citings provided by the World Health Organization (WHO), approximately 20 to 25 million people worldwide are linked with genetic traits associated with sickle cell disease. It is a genetic disorder in which there are not enough healthy red blood cells to carry oxygen in different parts of the human body. Myeloproliferative diseases will be registering rampant market growth owing to the fast track designation status awarded to hydroxycarbamide for the treatment of rare diseases such as chronic myeloid leukemia and polycythemia Vera etc.

Browse the full report Hydroxycarbamide Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/hydroxycarbamide-market

Hospital pharmacy is reigning the distribution channel segment for the hydroxycarbamide market. Hydroxycarbamide is a potent antineoplastic agent in which accurate compounding according to physicians prescription is essential in order to prevent drug-related adverse events. It needs to be strictly taken under medical supervision owing to its toxic nature. Retail pharmacy is gaining strong grounds in the developing nations on account of its ability to sell different generic versions of hydroxycarbamide at affordable prices.

North America is currently dominating the largest market in the geography segment for the hydroxycarbamide market. The rising prevalence of sickle cell disease chiefly drives the hydroxycarbamide market growth in the region. As per the latest statistics presented by the Center for Disease Control and Prevention (CDC), sickle cell disease affects approximately 100,000 Americans, the incidence rate is 1 in 365 African-American births, and 1 in 16,300 Hispanic-American birth, etc. Affordable reimbursement scenario and the existence of well-developed healthcare infrastructure further bolster the market growth in the region. Europe stands 2nd in the regional segment for the hydroxycarbamide market. The supportive regulatory environment provided by the European Medical Agency (EMA) for the sale and distribution of hydroxycarbamide primarily drives the market growth in the European Union region. Furthermore, the strategic partnership between academic research institute and pharmaceutical companies to validate the therapeutic efficacy of hydroxycarbamide in the treatment of psoriasis further consolidates the market growth in the region. The Asia Pacific will register rampant growth in the regional segment on account of the rising prevalence of cervical cancer in women population and the presence of a well-developed generic drug market in the Asia Pacific region.

Pharmaceutical companies actively engaged in the manufacturing of hydroxycarbamide areBristol Myers Squibb & Company, Teva Pharmaceutical Industries Ltd., Sandoz, Inc., HEXAL AG., Cadila Healthcare, Cipla Limited, AvKARE, Inc., Par Pharmaceutical, Apotex Corporation, and Addmedica.

Market Key Takeaways:

  • Significant increase in the number of patients suffering from sickle cell disease worldwide
  • Increasing research activities conducted in clinical trials investigation to harness the therapeutic efficacy of hydroxycarbamide to treat chronic myeloid leukemia and psoriasis
  • Constant rise in retail pharmacy and well established generic drugs market in the developing regions to propel the hydroxycarbamide market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Fosfomycin Market Is Expected to Grow at a CAGR of 3.2% from 2020 to 2027

Fosfomycin is a broad-spectrum antibiotic having activity against gram-negative and gram-positive bacteria, it exerts its pharmacological activity by causing interference in the production of the bacterial cell wall. It is enlisted in the World Health Organization (WHO), list of essential medicines.

Urinary tract infection is currently reigning the clinical application segment for the fosfomycin market. A significant increase in urban industrialization has led to the establishment of huge slums in the metropolitan cities having poor civic amenities. Residents of slum areas are repeatedly exposed to causative agents such as E.coli and E. faecalis and hence suffer from complicated urinary tract infection with a 50% recurrence in previously affected patients. According to the World Health Organization (WHO), approximately 150 million people worldwide are affected by urinary tract infections each year. Prostatitis is anticipated to be the fastest-growing clinical application segment during the forecast period. A constant rise in a geriatric population having frequent urine leakage in the prostate glands and previous nerve or muscle injury in the lower urinary tract are responsible for the occurrence of prostatitis infection in the adult male population throughout the globe.

Browse the full report Fosfomycin Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/fosfomycin-market

Hospital pharmacy is leading the distribution channel segment for the fosfomycin market. Fosfomycin is a broad-spectrum antibiotic-associated with severe drug-related side effects thus it is necessary for the hospital pharmacist to precisely compound the fosfomycin to negate the occurrence of any adverse events. Retail pharmacy is gaining tremendous demand in developing countries due to the presence of a well-developed generic drug market and the availability of medicines at affordable prices.

North America is presently dominating the geography segment for the fosfomycin market. The rising prevalence of prostatitis in the adult male population primarily drives the fosfomycin market growth in the region. As per the latest research citings provided by the Center for Disease Control and Prevention (CDC), the incidence rate of prostatitis in the male population in the United States is 4.9% per 1000 people each year. Furthermore, the domicile of major players in the region such as Verity Pharmaceuticals, Inc., Abbvie, Jamp Pharma Corporation, etc. further propels the market growth in the region. Europe is the second-largest regional segment for the fosfomycin market. Rising prevalence of healthcare-associated urinary tract infection (HAUTIs) determines the fosfomycin market growth in the region. According to the latest statistics presented by the European Commission report, the prevalence rate of HAUTIs is 19.6% in the region. Asia Pacific is set to be the fastest-growing regional segment for fosfomycin market. A significant increase in water and soil population has led to a constant rise in urinary tract infection in people residing in the slums. Additionally, the presence of a flourishing generic drug market further accentuates the fosfomycin market growth in the Asia Pacific region.

Pharmaceutical manufacturers actively engaged in the production of fosfomycin are Verity Pharmaceuticals, Inc., Allergan, Plc. (Abbvie), Jamp Pharma Corporation, Mayne Pharma Group, Nabriva Therapeutics, Plc., Takeda Teva Pharma Ltd., Sun Pharmaceutical Industries Ltd., The Zambon Group, Infectopharm and Macleods Pharmaceuticals Pvt, Ltd.

Market Key Takeaways:

  • Rising prevalence of urinary tract infection worldwide
  • Significant increase in the number of cases of prostatitis in elderly population throughout the globe
  • Affordable reimbursement scenario for the fosfomycin drug formulation further bolster its market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Dietary Fiber Nutritional Supplements Market is expected to grow at a CAGR of 12.6% from 2020 to 2027

Nutritional science has undergone tremendous technical development in the last 5 decades eventually resulting in effective extraction from natural sources such as cereals, grains, fruits, and vegetables. Rising prevalence of gastrointestinal disorders, growing inclination for the consumption of unhealthy junk food, and sedentary lifestyle determines the dietary fiber nutritional supplements market growth. Proactive marketing of dietary fibers on social media will further accentuate the dietary fibers market growth in the near future.

The soluble dietary fibers are spearheading the type segment for dietary fiber nutritional supplements market. It is further sub-segmented as pectin, inulin, polydextrose, beta-glucan, etc. It usually forms a viscous gel-like substance when it comes in contact with the digestive fluid. It usually delays the digestion rate thereby reduces the feeling of hunger and food intake and is capable of maintaining a healthy weight. It has the ability to sequester blood cholesterol and is helpful in regulating blood glucose levels. It has been crucial in preventing the disease manifestation of chronic diseases such as cardiovascular disease and type 2 disease. Insoluble dietary fibers are gaining tremendous importance in their ability to maintain healthy gut flora and regulation of a peristaltic activity which is beneficial in treating chronic constipation.

Browse the full report Dietary Fiber Nutritional Supplements Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/dietary-fiber-nutritional-supplements-market

The supermarket is reigning the distribution channel segment in the dietary fiber nutritional supplements market. The chief contributing factors responsible for its market dominance are its inherent features such as lower operation and overhead cost and location in the central place of the city which attracts a huge customer base. It has the ability to display dietary fibers from several manufacturers and endorsed by different brands at competitive prices. E-commerce has gained tremendous traction in the last decade on account of a significant rise in the population using smartphones at the ability to reach a huge customer base with dietary fiber products at attractive discount rates.

North America is dominating the geography segment for the dietary fiber nutritional supplements market. The rising prevalence of the geriatric population suffering from gastrointestinal disorder primarily drives the market growth. Domicile of key players such as Archer Daniels Midland Company, BENEO, Cargill Corporation, DuPont, etc. further fortifies the dietary fiber nutritional supplements market in the region. Europe is in the 2nd place on account of the rising public health awareness regarding the useful application of insoluble fibers in achieving healthy gut microflora and peristaltic activity. The Asia Pacific is expected to register rampant market growth in the near future on account of the flourishing e-commerce segment which is providing a diverse range of dietary fiber products at affordable prices and attractive coupons.

Pharmaceutical companies manufacturing dietary fiber nutritional supplements are Archer Daniels Midland Company, Royal DSM, Citrucel, Robinson Pharma, Inc., BENEO, Cargill Corporation, Tate & Lyle, Plc., Viachem, Meron Group, and DuPont.

Market Key Takeaways:

  • Rising prevalence of gastrointestinal disorders in the elderly population worldwide
  • Increasing public health awareness regarding the useful application of prebiotics in maintaining healthy gut microflora and motility
  • Flourishing e-commerce segment providing a diverse range of dietary fibers at affordable prices and attractive coupons

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Report Market Reports

Global Zirconium Dental Implants Market Is Expected To Grow At A CAGR Of 7.5% From 2020 To 2027

Zirconium dental implants are gaining huge demand in the dental surgery domain primarily due to its ability to hide the metallic color and luster owing to its diamond translucent color. The superior ergonomic features associated with zirconia are excellent strength, robustness, biocompatibility, corrosion resistance, etc. It is being designed by the latest CADCAM technology to achieve an accurate fit in the oral cavity.

An endosteal dental implant is currently leading the type segment for the zirconium dental implants market. It is the most common type of surgery performed by dentists worldwide. In this surgery usually the implant is directly inserted in the jawbone, and after the gum tissues are healed a second surgery is performed to connect the post to the original implant on which artificial tooth is mounted. In Subperiosteal implants the metal frame is usually placed in the jawbone just below the gums. When the gum tissue is healed the metal frame gets attached to the jawbone and the tooth is mounted on the protruding posts.

Browse the full report Zirconium Dental Implants Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/zirconium-dental-implants-market

Hospitals and clinics are spearheading the end-user segment for the zirconium dental implants market. The constant increase in the number of patients visiting dental facilities for treating dental deformities at subsidized prices in government-funded hospitals and clinics. The presence of well-equipped dental surgery kits and accessories further consolidates the market growth of hospitals and clinics. It is anticipated that the dental laboratories are going to gain huge market traction in the developing regions owing to the rising prevalence of dental caries associated with tobacco and betel nuts chewing and constant rise in the number of dental laboratories established in remote areas.

North America is presently representing the largest market share in the geography segment for the zirconium dental implants market. According to the latest statistics provided by the Center for Disease Control and Prevention (CDC), in the United States, the percentage of children and adults visiting the dentist for untreated dental caries is 84.9% and 64.0% respectively. The presence of major players such as 3M Company, Zimmer Biomet, and Dentsply Sirona, etc. further accelerates the zirconium dental implants market growth. In Europe the market growth is determined by the rising prevalence of edentulism in the geriatric population and proactive role adopted by the European Medical Agency for the early clearance of zirconium dental implants in the region. Asia Pacific is set to register impressive market growth in the near future on account of the significant rise in the medical tourism industry and a rise in per capita income of middle-income households.

Medical device manufacturers pioneering in the manufacturing of zirconium dental implants are Straumann Group, Zimmer Biomet, KYOCERA Corporation, Osstem Implants Company, Dentsply Sirona, TAV Dentsply Ltd., 3M Company, Nobel Biocare Services AG, Glidewell Dental and Z-Systems AG.

Market Key Takeaways:

  • Rising prevalence of dental deformities across all age group throughout the world
  • Technological advancement in the zirconium dental implants rendering it useful for Endosteal and subperiosteal dental implants
  • Supportive regulatory environment provided by the global regulatory agencies for its early clearance and adoption

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Report Market Reports

Global Human Prothrombin Complex Market is expected to grow at a CAGR of 5.8% from 2020 to 2027

According to the latest research citings presented by the National Hemophilia Foundation (NHF), worldwide there are approximately 400,000 people suffering from hemophilia. The human prothrombin complex is a concentrate of blood clotting factors such as factor II, VII, IX, X etc., which is available in the dose strength of 500 unit/vial, 1000 unit/vial. The dose calculation needs to be accurate while administering the human prothrombin complex in order to prevent the occurrence of any adverse events such as thromboembolic events, headache, hypotension, nausea, vomiting, etc.

Vitamin K antagonist reversal is spearheading the clinical application segment for the human prothrombin complex market. The therapy is vital in controlling the adverse side effects associated with blood-thinning agents such as intracranial hemorrhage, prolonged nosebleeds, etc. Inherited bleeding disorders will be the fastest-growing segment during the forecast period. A significant rise in the number of patients suffering from Hemophilia A, B, Von Willebrand disease, etc. accentuates the human prothrombin complex market growth.

Browse the full report Human Prothrombin Complex Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/human-prothrombin-complex-market

Hospitals are reigning the end-users segment for human prothrombin complex market. Patients suffering from profuse bleeding are kept under medical supervision in the medical emergency units of hospitals. Dose calculation of the human prothrombin complex is very critical which is performed accurately in the hospitals. Clinics are anticipated to register faster market growth in the near future on account of early clearance approved by the government healthcare agencies in order to establish a maximum number of clinics to reduce healthcare burden associated with hospitals.

North America is presently dominating the geography segment for the human prothrombin complex market. Increasing demand for vitamin K antagonist reversal therapy in patients receiving blood-thinning drugs for treating cardiovascular disorders. The existence of well-developed healthcare infrastructure and the presence of key players such as Baxter AG, Octapharma AG, CSL Behring, Shire, Plc., etc. further propel the market growth in the region. Europe is the second-largest market in the regional segment for the human prothrombin complex on account of the rising prevalence of hemophilia across all age groups. As per the latest research citings presented by the European Hematology Network (EUHANET), the prevalence rate of Hemophilia A and B is 1 in 10,000 and 1 in 50,000 population respectively. Asia Pacific is set to register sturdy market growth during the forecast period owing to the lucrative market opportunity for the western pharmaceutical giants to establish retail outlets and subsidiaries in the region and developing healthcare infrastructure.

Biopharmaceutical companies actively engaged in the manufacturing of human prothrombin complex are Shire, Plc., Grifols S.A., Octapharma AG., Hualan Biological Engineering, Inc., CSL Behring., Baxter AG., Bio Products Laboratory, Limited., Sanquin., Cangene Biopharma., and Novo Nordisk A/S.

Market Key Takeaways :

  • Increasing demand for vitamin K antagonist reversal therapy in patients receiving blood-thinning drugs to treat cardiovascular complications
  • Rising prevalence of inherited bleeding disorders throughout the globe
  • Technological advancement in the development of human prothrombin complex from human plasma and recombinant technology

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Report Market Reports

DC Electric Cable Market Is Expected to Grow at a CAGR of XX from 2020 to 2027

The DC electric cable market is flourishing with the rear of expanding urbanization and quickly developing structure foundation, combined with developing organization of sun powered boards, expanding sending of HVDC transmission, and ascend in the number of electronic gadgets. Moreover, rising utilization of vitality worldwide on the rear of developing interest for electrical and gadgets is raising the requirement for execution of safe and made sure about electrical dispersion frameworks, which incorporates wires and cables, suitable connectors, and others, which is additionally foreseen to contribute towards the development of the worldwide DC electric cable market. Besides, raising worries for security and fire-related events hung on the rear of the organization of wrong wires and cables determined for use in electrical and electronic frameworks is additionally expected to contribute essentially towards the development of the worldwide DC electrical cable market. As indicated by the measurements by the National Fire Protection Association (NFPA), a portion of home fire happened from wiring and related gear established to 67% in the middle of the period 2012-2016.

Browse Full Report DC Electric Cable Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/dc-electric-cable-market

The market is foreseen to record a strong CAGR all through the figure time frame, for example, 2020-2027. The worldwide DC electric cable market is fragmented by end client into utilities and force lattices, IT and telecom, car and transportation, gadgets and others, out of which, utilities and force networks section is foreseen to hold the biggest market share attributable to moving pattern for cost-effective force circulation, alongside developing pattern of savvy framework electricity dispersion frameworks. DC electric cables (string DC cables) are generally utilized in interfacing sun-based boards to the sun-based charge controller framework. Further, fundamental DC cables are used in interfacing the framework to the matrix. Also, the car and transportation section is foreseen to increase huge market share in the worldwide DC electric cable market by virtue of rising creation of autos around the world and rising interest for electric vehicles. Vehicles are fueled with DC batteries inferable from which, DC cables are conveyed for the general wiring of the vehicle. As indicated by the measurements by the International Energy Association (IEA), electric vehicle sending on the planet expanded from 0.23 Mn in the year 2013 to 3.29 Mn in the year 2018.

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Outlook Market Report Market Reports

Global Amifostine Hydrate Market Is Expected To Grow At A CAGR Of 2.8% From 2020 To 2027

Amifostine Hydrate was originally developed by the military as a radioprotectant during the event of a nuclear attack. It is basically a prodrug that is dephosphorylated in the tissues by alkaline phosphatase into a free thiol metabolite which is critical in reducing the toxic effects of chemo and radiation therapy on healthy cells.

According to the European Society for Medical Oncology (ESMO), head and neck cancer has a global incidence rate of 3.9 and 2.3% per 100,000 people worldwide. Xerostomia is an adverse event associated with radiation therapy which is recommended in patients suffering from head and neck cancer. The recommended dose for xerostomia treatment is 200 mg/m2 once every day as a 3-minute infusion usually 15 minutes before radiation therapy. Nephrotoxicity or cumulative renal toxicity is associated with patients receiving cisplatin chemotherapy. The recommended dose for nephrotoxicity treatment is 910 mg/m2 once every day as a 15 minutes infusion, it needs to be given 30 minutes prior to chemotherapy and the blood pressure needs to be constantly monitored every 5 minutes during the infusion.

Browse the full report Amifostine Hydrate Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/amifostine-hydrate-market

Hospitals & clinics are spearheading the end-user segment for the Amifostine Hydrate market. Constantly increasing inpatient admission of patients suffering from cancer and Availability of Amifostine Hydrate injection at a low cost in the government-funded hospitals and clinics determine its market growth. Rehabilitation centers are gaining huge demand on account of its ability to reduce mental distress and improve physical health in cancer patients receiving long term chemotherapy and radiation therapy.

North America is presently holding the largest market share in the geography segment for the Amifostine Hydrate market. As per the research findings brought forward by the Center for Disease Control and Prevention (CDC), ovarian cancer is considered the second most common gynecological cancer in women in the United States. The rising prevalence of nephrotoxicity associated with cisplatin chemotherapy primarily drives the market growth in North America. Domicile of key players such as Cumberland Pharmaceuticals, Mylan Labs Ltd., Natco Pharma Limited, etc further fortifies the market growth in the region. According to the statistics presented by the European Society for Medical Oncology Head and Neck, cancer accounts for 3%  of all cancer cases owing to the significant increase in smoking and tobacco consumption. A significant rise in Xerostomia associated with radiation therapy determines the market growth in Europe. It is anticipated that the Asia Pacific will register comfortable market growth during the forecast period on account of the presence of a huge generic drug market and increasing the medical tourism industry.

Pharmaceutical companies manufacturing Amifostine Hydrate injections are Cumberland Pharmaceuticals, Mylan Labs Ltd., CSC Pharmaceuticals International, Natco Pharma Limited, Clinigen Group, Sun Pharmaceutical Industries Ltd., Taj Pharmaceuticals Limited, Merro Pharmaceutical Co., Ltd. Luye Pharma Group and Mingren Pharma.

Key Market Movements:

  •    Rising prevalence of nephrotoxicity and xerostomia associated with chemotherapy and radiation therapy
  •   Availability of generic version single vial injection for intravenous administration at a relatively low price
  •   Popular among oncologists as an adjuvant therapy in cancer treatment owing to its cytoprotective activity.

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Diesel Exhaust Fluid (DEF) Market is Expected to Reach XX By 2027

The global diesel exhaust fluid (DEF) market is blossoming with the rear of expanding deals of traveler and business vehicles around the world, alongside progression in advancements in motor exhaust frameworks. Throughout the years, vehicle producers around the world are progressively spending on innovative work for discovering new advances that expand the proficiency of a vehicle and discharge less contamination to the earth. With the rising interest for vehicles all around the world, the market of global diesel exhaust fluid (DEF) is along these lines foreseen to become exponentially throughout the years. As indicated by the International Organization of Motor Vehicle Manufacturers (OICA), deals of vehicles around the world expanded from 65.9 Mn in the year 2005 to 95.1 Mn in the year 2018.

The global diesel exhaust fluid (DEF) market is foreseen to record a CAGR of around 10.2% all through the conjecture time frame, for example, 2020-2027. The market is fragmented by vehicle type into business and traveler vehicles. The business portion is additionally divided into the light business vehicle, overwhelming business vehicle and transports, and mentors, out of which, the light business vehicle is foreseen to hold the biggest piece of the pie on the rear of expanding interest for light business vehicles around the globe. Developing a number of new organizations alongside the requirement for quick and proficient administrations among business organizations is raising the requirement for the sending of vehicles that can utilize in the city and can serve in profound inside fragments where enormous vehicles can’t reach. In addition, dynamic change in the business working models is additionally contributing towards the more prominent acknowledgment of LCVs among business organizations. As per OICA, among all the sort of business vehicles delivered, the light business vehicle portion overwhelmed the biggest portion of creation in both the year 2017 and 2018 with a portion of 82.19% and 82.39% separately.

Browse Full Report Diesel Exhaust Fluid (DEF) Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 At https://www.atlanticmarketresearch.com/diesel-exhaust-fluid-market

As indicated by the World Health Organization (WHO), street transport, for the most part, diesel traffic, is viewed as a significant patron towards particulate air contamination. Furthermore, it additionally assessed that in the European urban areas, street transport added to around 30% of particulate discharges, trailed by half in OECD nations.

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Physiological Saline Market is Expected to Grow at a CAGR of 2.4% from 2020 to 2027

Physiological saline is also called 0.9% sodium chloride solution which is made by dissolving 9 grams of sodium chloride in 1 liter of sterile, pyrogen-free, non-toxic water. It is acidic in nature with a pH of 5.5, proper precaution must be taken while administrating intravenous fluids to negate adverse reactions such as phlebitis, extravasation, and hypervolemia.

Replacement fluid therapy is reigning the application segment for the physiological saline market. According to the latest information provided by the World Bank approximately more than 663 million people worldwide are subjected to water-borne infections which causes huge fluid loss due to diarrhea and vomiting. Fluid replacement therapy is vital in treating patients suffering from food poisoning as it performs vital functions such as regulating body temperature, maintaining blood flow and excreting toxins from the body, etc. Wound cleansing & irrigation will be registering comfortable market growth during the forecast period on account of a significant rise in wounds and burns associated with traumatic accidents and occupational hazards.

Browse the full report Physiological Saline Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/physiological-saline-market

Hospitals are leading the end-user segment for the physiological saline market. The key criterion which strengthens its market growth is that it is the first point of contact for patients to seek medical treatment for dehydration due to diarrhea and vomiting. Additionally, huge funding provided by government healthcare agencies to hospitals to provide optimum healthcare further propels its market growth. Clinics are anticipated to register rampant market growth in the near future on account of increasing waterborne infections in the developing regions.

Asia Pacific is presently dominating the geography segment for the physiological saline market. The major parameters accountable for its market dominance are the rising prevalence of foodborne infection causing severe dehydration. Additionally a significant increase in the number of patients visiting hospitals for the treatment of wounds and burns. Europe stood at 2nd position in the regional segment for the physiological saline market. As per the latest information obtained from the European Commission report, annually 33,000 Europeans die due to antibiotic-resistant infection. North America will be the fastest-growing geography segment for the physiological saline market. According to the latest statistics presented by the Center for Disease Control and Prevention (CDC), annually 128,000 U.S. citizens are hospitalized subjected to food poisoning. The presence of major players such as Baxter AG, Hospira, B.Braun Melsungen AG, etc. will further empower the market growth in the region.

Pharmaceutical companies actively engaged in providing of physiological saline solutions are Merck KGaA., Expanscience Laboratories, Baxter AG, Fresenius Kabi, B. Braun Melsungen AG., Otsuka Pharmaceuticals., Hospira (Pfizer, Inc.), Grifols S.A., ICU Medical, Inc. and Cardinal Health.

Market Key Takeaways:

  • Significant increase in the number of water and foodborne infections causing dehydration worldwide
  • A constant rise in the number of traumatic accidents often resulting in wounds and burns
  • Increasing establishment of specialty clinics by corporate conglomerated will further propel physiological saline market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Gonadorelin Acetate Market Is Expected to Grow at a CAGR of 3.4% from 2020 to 2027

Gonadorelin is basically a synonym for gonadotropin-releasing hormone, it is a synthetic decapeptide which is vital in releasing the follicle-stimulating hormone (FSH) and luteinizing hormone from the anterior pituitary gland.

Amenorrhea is dominating the clinical application segment for the gonadorelin acetate market. The early menarche is the female population is the most visible clinical manifestations encountered, the causative agents responsible for the disease prognosis of amenorrhea in the young female population are deficiency of the gonadotropin-releasing hormone, physical or emotional stress, etc. In the developed regions worldwide there has been a rampant increase in infertility at a higher rate owing to the factors such as early age obesity, sedentary lifestyle, unhealthy diet, etc. which diminishes the release of gonadotropin-releasing hormone which promotes both the growth and release of mature eggs from the ovaries. Veterinary use is expected to register rampant market growth in many countries across the globe, due to the therapeutic efficacy of gonadorelin to treat cystic ovaries in dairy cattle and synchronize estrous cycles in lactating cows.

Browse the full report Gonadorelin Acetate Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/gonadorelin-acetate-market

Hospital pharmacy is currently spearheading the distribution channel segment for the gonadorelin acetate market. Accurate drug compounding must be done by the hospital pharmacist in cognizance of the physician’s prescription to negate the possibility of drug-related adverse events. Retail pharmacy is gaining huge demand worldwide owing to its ability to cater medical assistance to people residing in remote locations market and availability of gonadorelin acetate for veterinary use at affordable price.6

North America is presently leading the geography segment for the gonadorelin acetate market. The rising prevalence of infertility in the women population determines the gonadorelin acetate market growth in the region. According to the latest research citings presented by the Center for Disease Control and Prevention (CDC), approximately 10 in 100 women which is equivalent to 6.1 million women population in the United States face difficulty with pregnancy. Sedentary lifestyle and obesity is the major causative factor for the occurrence of early menarche in young females. Recently USFDA has given approval to Fertagyl® for its ability to treat cystic ovaries in dairy cattle. Europe is the second-largest regional segment for the gonadorelin acetate market. The rising prevalence of amenorrhea in the European Union region propels the gonadorelin acetate market growth. According to the statistics provided by the European Commission report, the prevalence rate of amenorrhea in the young female population ranges from 1.8% to 3% in the European region. Asia Pacific is anticipated to be the fastest-growing regional segment for the gonadorelin acetate market. Rising prevalence of infertility in women population due to lack of nutritious diet and flourishing generic drugs market together drive the gonadorelin acetate market growth in the Asia Pacific.

Pharmaceutical manufacturers actively engaged in the production of gonadorelin acetates are Ferring Pharmaceuticals, Mitsubishi Tanabe Pharma., Zoetis, Inc., Toronto Research Chemicals, Intrapharm Laboratories, Hemmo Pharmaceuticals, Sanofi Aventis, LKT Laboratories, Inc., Laboratorios Syva., and Parnell Pharmaceuticals.

Market Key Takeaway:

  • Significant increase in the number of the female population suffering from infertility and amenorrhea worldwide
  • Therapeutic efficacy of gonadorelin acetate in the treatment of cystic ovaries in dairy cattle
  • Supportive regulatory environment for the manufacturing and sale of gonadorelin acetate across the globe

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Deferasirox Market is expected to grow at a CAGR of 4.2% from 2020 to 2027

Deferasirox is an iron-chelating agent which is the most popular drug which is prescribed to reduce excess iron overload in blood disorder patients requiring frequent blood transfusion. It is available in different formulation for oral administration such as 90mg & 180mg film-coated tablets and tablet for suspension the composition are 125mg, 250mg, and 500mg, etc.

Transfusional hemosiderosis is spearheading the indication segment for the deferasirox market. Deposition of excess iron in the visceral organs such as liver, heart, and other endocrine glands takes place in the patients who receive blood transfusion for treating blood disorders such as sickle cell anemia, myelodysplastic syndrome, sickle cell anemia, etc. Deferasirox is recommended after the transfusion of 20 units of packed red blood cells or clinical evidence is reporting chronic iron overload for e.g. the serum ferritin level is greater than 1,000 µg/l associated with blood transfusion. Non-transfusion-dependent thalassemia syndromes are anticipated to be the rampant growing indication segment in the near future majorly due to the constant increase in the number of patients suffering from thalassemia syndromes. Deferasirox is recommended after clinical evidence has reported the iron overload as serum ferritin levels consistently greater than 800 µg/l in patients suffering from thalassemia syndromes.

Browse the full report Deferasirox Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/deferasirox-market

Hospital pharmacy is currently leading the distribution channel segment for the deferasirox market. Deferasirox is prescribed in different formulation and composition to reduce the burden associated with the chronic deposition of iron in the liver. Hospital pharmacist ensures precise compounding of deferasirox dose per body weight in order to reduce drug adverse events such as renal and hepatic function disorders etc. Retail pharmacy is becoming very popular in the developing regions due to the existence of competitive generic drugs market at affordable prices.

North America is currently reigning the geography segment for the deferasirox market. As per the statistics presented by the National Institute of Health (NIH), it is estimated that about 1% of the U.S. population is reported for suffering from nonmalignant blood disorders. Affordable reimbursement scenario for the deferasirox drug formulation used as an iron-chelating agent further propels the market growth in the region. Europe is in the 2nd largest market holder in the regional segment primarily due to the constant rise in the number of patients suffering from non-transfusion-dependent thalassemia syndromes. As per the research citings brought forward by the Health Programme of The European Union, the annual incidence of symptomatic cases associated with beta-thalassemia in the European Union is 1 per 10,000 people. The Asia Pacific will be the fastest-growing regional segment in the near future owing to the presence of a lucrative market for generic medicines and a constant rise in the number of patients suffering from chronic liver iron overload due to frequent blood transfusions.

Pharmaceutical manufacturers actively engaged in the production of deferasirox drug formulation are Novartis AG, Sun Pharmaceutical Industries Ltd., Apotex Corporation, Zydus Pharmaceuticals, Inc., Alembic Pharmaceuticals Limited., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories. Farma-Tek Pharmaceuticals. Bioprofarma Bagó, and AC Farma S.A.

Market Key Takeaways:

  • Significant rise in the number of blood-related disorders requiring frequent blood transfusion
  • Rising prevalence of beta-thalassemia major disorder worldwide
  • The supportive regulatory environment provided by the healthcare regulatory agencies pertaining to the sale and distribution of different formulation of deferasirox throughout the globe

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Avanafil Market Is Expected To Grow At A CAGR of 5.8% From 2020 To 2027

Avanafil is becoming very popular for the treatment of erectile dysfunction (ED) in comparison with other phosphodiesterase-5 (PDE5) inhibitors due to faster onset of action, longer duration of activity and excellent tolerability in elderly patients suffering from ED. The mechanism of action associated with the drug is that it inhibits cGMP specific phosphodiesterase type 5 (PDE5) and triggers cGMP mediated triggers smooth muscle relaxation and increase in the blood flow in the corpus cavernosum region of the penis.

In the present situation, the demographics of 60 years and above are dominating the Avanafil market. The erectile dysfunction (ED) is said to occur concomitantly with aging. The etiology associated with ED is complex and is said to be associated with anomalies associated with hormonal levels, vascular and smooth muscle functioning of corpus cavernosum. The demographics of the 21-39 age group are keen to register rampant market growth owing to the significant rise in smoking, alcoholism, obesity, and type 2 diabetes which results in reduced blood flow in the penile smooth muscles and stressful lifestyle drastically reducing sexual drive.

Browse the full report Avanafil Market  – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/avanafil-market

Hospital pharmacy is reigning the distribution channel segment for the Avanafil market. The major contributing factors responsible for its market growth are that is the first point of contact for patients to purchase physicians drug prescription. Availability of skilled pharmacists to dispense the right dosage of medicine according to the patient’s body mass index and thereby drastically reducing adverse events associated with high drug dosage. E-commerce is set to register faster market growth on account of the huge consumer base using smartphones and the ability to meet the medical requirements of patients in remote locations due to superior logistics.

North America is currently holding the largest market share in the geography segment for Avanafil market. According to the statistics provided by the pharmaceutical company Vivus, Inc., approximately more than 30 million men in the United States are suffering from erectile dysfunction. The constant rise in diabetic men population with reduced sexual drive will further propel the Avanafil market growth. Europe is in the 2nd position on account of the rising prevalence of erectile dysfunction across all age groups. As per the research citings brought forward by the European Association of Urology, the prevalence rate of erectile dysfunction in the European region is 19.2% and is anticipated to increase due to a significant rise in smoking, alcoholism, and diabetes. The Asia Pacific is keen to register healthy market growth for Avanafil due to a huge geriatric population base and provides lucrative market opportunities for major players to enter into licensing agreement with local players.

Pharmaceutical companies pioneering in the manufacture of Avanafil are Vivus, Inc., Metuchen Pharmaceuticals, Menarini Group, JW Pharmaceuticals, Acerus Pharmaceuticals, and Sunrise Remedies Private Limited.

Market Key Takeaways:

  • Rising prevalence of erectile dysfunction in elderly population throughout the globe
  • The constant rise of erectile dysfunction in middle-aged population due to the constant rise in obesity, smoking, alcoholism, and diabetes
  • Supportive regulatory environment for the market growth of Avanafil

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]